Skip to content
GLP-1 Scorecard
Menu
Graded #35

Direct Meds

One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.

Visit Direct MedsWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$249/mo sublingual · $297/mo injectable
Tirzepatide
$299/mo sublingual · $399/mo injectable
Coverage
Not publicly listed
Brand-name
Compounded only

Weigh Direct Meds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Direct Meds dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value85/100
Dose & formulation88/100
Clinical oversight55/100
Labs & monitoring78/100
Fulfillment80/100
Contract terms80/100

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed

Bottom line — Grade C+

Best for: Patients who specifically want a non-injection option on both molecules under an all-inclusive price, and are comfortable with a newer operator whose pricing they'll want to confirm directly.

Ranked #35 of 536 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Closest here

The rankings grading nearest Direct Meds — the realistic shortlist.

Bodybuilding Health+#33

The Bodybuilding.com fitness brand's new compounded-telehealth arm — cheap semaglutide that genuinely falls from $179/mo to $139/mo if you prepay a year, sitting next to a tirzepatide line whose bundles cost MORE per month ($286/$250/$244) than its $209 month-to-month rate, on top of a deep sermorelin/NAD+/peptide bench; honest FDA labeling, but brand-new, compounded, and final-sale, so it lands as a value runner-up rather than a top pick.

Peter MD#34

A Miami-founded telehealth that starts tirzepatide at $149 the first month (then $249/mo, billed quarterly) and runs semaglutide, TRT, sermorelin and NAD+ on the same account.

Vaylen#46

Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.

Amazon One Medical#47

Amazon One Medical is the unified Amazon GLP-1 channel — One Medical clinicians prescribe FDA-approved Wegovy, Zepbound, and Foundayo (no compounded products), and Amazon Pharmacy fulfills with same-day delivery across roughly 3,000 US cities plus pickup kiosks at select One Medical locations.

Henry Meds#48

A flat-fee compounded pioneer — simple, but priced at the higher end of the ranking now.

Revel RX#49

Revel RX is a Michigan-based telehealth weight-loss platform offering compounded semaglutide at $89/month and compounded tirzepatide at $155/month — flat-rate at every dose tier.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Direct Meds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Direct Meds's site. Not medical advice; see our disclosure.

← Back to the scorecard